Literature DB >> 16989730

A subpopulation of peritoneal macrophages form capillarylike lumens and branching patterns in vitro.

Mirela Anghelina1, Leni Moldovan, Tahera Zabuawala, M C Ostrowski, N I Moldovan.   

Abstract

OBJECTIVE: We have previously shown that monocytes/macrophages (MC/Mph) influence neovascularization by extracellular matrix degradation, and by direct incorporation into growing microvessels. To date, neither the phenotype of these cells, nor the stages of their capillary-like conversion were sufficiently characterized.
METHODS: We isolated mouse peritoneal Mph from transgenic mice expressing fluorescent proteins either ubiquitously, or specifically in the myelocytic lineage. These Mph were embedded in Matrigel which contained fluorescent protease substrates, exposed to an MCP-1 chemotactic gradient, and then examined by confocal microscopy after various intervals.
RESULTS: Within 3 hrs after gel embedding, we detected TIMP-1 and MMP-12 dependent proteolysis of the matrix surrounding Mph, mostly in the direction of high concentrations of MCP-1. After 2 days, Mph developed intracellular vacuoles containing degradation product. At 5 days these vacuoles were enlarged and/or fused to generate trans-cellular lumens in approximately 10% of cells or more (depending on animal's genetic background). At this stage, Mph became tubular, and occasionally organized in three-dimensional structures resembling branched microvessels.
CONCLUSION: Isolated mouse peritoneal Mph penetrate Matrigel and form tunnels via a metalloprotease-driven proteolysis and phagocytosis. Following a morphological adjustment driven by occurrence, enlargement and/or fusion process of intracellular vacuoles, similar to that described in bona fide endothelium, a subpopulation of these cells end up by lining a capillary-like lumen in vitro. Thus we show that adult Mph, not only the more primitive 'endothelial progenitors', have functional properties until now considered defining of the endothelial phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989730      PMCID: PMC3933152          DOI: 10.1111/j.1582-4934.2006.tb00430.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  31 in total

1.  Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation.

Authors:  K Horino; A L Kindezelskii; V M Elner; B A Hughes; H R Petty
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

2.  Circulating endothelial cells after transplantation.

Authors:  E Gunsilius; A L Petzer; H C Duba; C M Kahler; G Gastl
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

Review 3.  In vitro transformation of monocytes and dendritic cells into endothelial like cells.

Authors:  Klaus Havemann; Beatriz F Pujol; Jürgen Adamkiewicz
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 4.  An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices.

Authors:  George E Davis; Kayla J Bayless
Journal:  Microcirculation       Date:  2003-01       Impact factor: 2.628

5.  Endothelial tubes assemble from intracellular vacuoles in vivo.

Authors:  Makoto Kamei; W Brian Saunders; Kayla J Bayless; Louis Dye; George E Davis; Brant M Weinstein
Journal:  Nature       Date:  2006-06-21       Impact factor: 49.962

6.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions.

Authors:  A Schmeisser; C D Garlichs; H Zhang; S Eskafi; C Graffy; J Ludwig; R H Strasser; W G Daniel
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

7.  Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors.

Authors:  H Biermann; B Pietz; R Dreier; K W Schmid; C Sorg; C Sunderkötter
Journal:  J Leukoc Biol       Date:  1999-02       Impact factor: 4.962

8.  Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions.

Authors:  S Suomela; A L Kariniemi; E Snellman; U Saarialho-Kere
Journal:  Exp Dermatol       Date:  2001-06       Impact factor: 3.960

9.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse.

Authors:  R Tedjo Sasmono; Delvac Oceandy; Jeffrey W Pollard; Wei Tong; Paul Pavli; Brandon J Wainwright; Michael C Ostrowski; S Roy Himes; David A Hume
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

10.  Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells.

Authors:  Soichiro Fujiyama; Katsuya Amano; Kazutaka Uehira; Masayuki Yoshida; Yasunobu Nishiwaki; Yoshihisa Nozawa; Denan Jin; Shinji Takai; Mizuo Miyazaki; Kensuke Egashira; Takayuki Imada; Toshiji Iwasaka; Hiroaki Matsubara
Journal:  Circ Res       Date:  2003-10-02       Impact factor: 17.367

View more
  11 in total

1.  Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices.

Authors:  Amber N Stratman; W Brian Saunders; Anastasia Sacharidou; Wonshill Koh; Kevin E Fisher; David C Zawieja; Michael J Davis; George E Davis
Journal:  Blood       Date:  2009-04-01       Impact factor: 22.113

Review 2.  EPCs and pathological angiogenesis: when good cells go bad.

Authors:  Sergio Li Calzi; Matthew B Neu; Lynn C Shaw; Jennifer L Kielczewski; Nicanor I Moldovan; Maria B Grant
Journal:  Microvasc Res       Date:  2010-02-25       Impact factor: 3.514

3.  IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.

Authors:  Kyung-Hee Chang; Tailoi Chan-Ling; Evan L McFarland; Aqeela Afzal; Hao Pan; Louise C Baxter; Lynn C Shaw; Sergio Caballero; Nilanjana Sengupta; Sergio Li Calzi; Sean M Sullivan; Maria B Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-13       Impact factor: 11.205

Review 4.  The chemokine system in arteriogenesis and hind limb ischemia.

Authors:  Paula K Shireman
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

5.  Multiple myeloma macrophages: pivotal players in the tumor microenvironment.

Authors:  Simona Berardi; Roberto Ria; Antonia Reale; Annunziata De Luisi; Ivana Catacchio; Michele Moschetta; Angelo Vacca
Journal:  J Oncol       Date:  2013-01-30       Impact factor: 4.375

6.  Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.

Authors:  Bernard Caillou; Monique Talbot; Urbain Weyemi; Catherine Pioche-Durieu; Abir Al Ghuzlan; Jean Michel Bidart; Salem Chouaib; Martin Schlumberger; Corinne Dupuy
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

Review 7.  Monocyte transplantation for neural and cardiovascular ischemia repair.

Authors:  Paul R Sanberg; Dong-Hyuk Park; Nicole Kuzmin-Nichols; Eduardo Cruz; Nelson Americo Hossne; Enio Buffolo; Alison E Willing
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

8.  The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish.

Authors:  Chris Hall; Maria Vega Flores; Thilo Storm; Kathy Crosier; Phil Crosier
Journal:  BMC Dev Biol       Date:  2007-05-04       Impact factor: 1.978

9.  Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction.

Authors:  C Troidl; H Möllmann; H Nef; F Masseli; S Voss; S Szardien; M Willmer; A Rolf; J Rixe; K Troidl; S Kostin; C Hamm; A Elsässer
Journal:  J Cell Mol Med       Date:  2009-02-17       Impact factor: 5.310

Review 10.  Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.

Authors:  Miguel Angel Medina; Ramón Muñoz-Chápuli; Ana R Quesada
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.